ArticleJournal of fluorescence2026
Fluorescence spectroscopy as a tool for differentiating methicillin resistance in clinical isolates of Staphylococcus aureus.
Article in Journal of fluorescence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Fluorescence spectroscopy is a potential diagnostic tool for the characterization and differentiation of microbial species. This research article explores the potential of Fluorescence spectroscopy to differentiate Methicillin Resistant Staphylococcus aureus (MRSA) from Methicillin Sensitive Staphylococcus aureus (MSSA) based on their unique spectral features. MRSA infections are more challenging to treat so their rapid and accurate identification can ensure timely administration of required antibiotics, thus countering the growing threat of antimicrobial resistance. In this study 101 clinical isolates of MRSA and MSSA were used to validate fluorescence emission spectral fingerprints. Fluorescence spectra for each of these isolates were obtained by excitation of bacterial colony at 405 nm. The emission spectra of both phenotypes were clearly differentiated by their emission bands at 510 and 550 nm. Furthermore, Principal component analysis (PCA) was applied to further highlight spectral variations, which showed a good reproducibility among the emission spectra of same bacterial strains. In conclusion, Fluorescence spectroscopy has proved to be a reproducible and effective tool for up to 100% accurate differentiation of MRSA and MSSA isolates, offering a rapid, simple and convenient approach that would reduce the time as well as cost for detection of methicillin resistance in Staphylococcus species.
Indexed as
Identifiers
41273537What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.